Showing results (221-230 of 226) with videos related to
Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 226 results.
Canadian Family Physician Medecin De Famille Canadien|June 17, 2024
Care-seeking experiences of unattached patients in the Canadian health care system: Qualitative studyMaria Mathews, Dana Ryan, Véronique Deslauriers, et al.Nursing Research and Practice|September 27, 2014
A systematic review of the cost-effectiveness of nurse practitioners and clinical nurse specialists: what is the quality of the evidence?Faith Donald, Kelley Kilpatrick, Kim Reid, et al.BMJ Open|March 21, 2025
Changing primary care capacity in Canada: protocol for a cross-provincial mixed methods studyM Ruth Lavergne, Julie Easley, Agnes Grudniewicz, et al.Bioorganic & Medicinal Chemistry|April 18, 2022
Discovery of (R)-(3-fluoropyrrolidin-1-yl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)quinolin-2-yl)methanone (ABBV-318) and analogs as small molecule Na<sub>v</sub>1.7/ Nav1.8 blockers for the treatment of painMeena V Patel, Hillary M Peltier, Mark A Matulenko, et al.Journal of Medicinal Chemistry|December 8, 2006
Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunctionMeena V Patel, Teodozyj Kolasa, Kathleen Mortell, et al.Journal of Medicinal Chemistry|September 27, 2017
Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain InhibitorKeith F McDaniel, Le Wang, Todd Soltwedel, et al.Pageof 23